Comparison effect of Pioglitazone and Glimepiride alone on renal function marker in experimentally induced renal damage in diabetic rats.

dc.contributor.authorKakadiya, Jagdish
dc.contributor.authorShah, Nehal
dc.date.accessioned2014-05-12T11:07:13Z
dc.date.available2014-05-12T11:07:13Z
dc.date.issued2011-04
dc.description.abstractPresent study was designed to evaluate in Renoprotective activity of Pioglitazone and Glimepiride on Ischemia/reperfusion (I/R) induced renal damage in diabetic rats. Ischemia/reperfusion injury, which is commonly seen in the field of renal surgery or transplantation in diabetic condition, is a major cause of acute renal failure. Type 2 Diabetes was induced in rats by a single intraperitoneal (i.p) injection of Streptozotocin (65 mg/kg, STZ) in overnight fasting rats followed by the i.p administration of Nicotinamide (110 mg/kg, NIC) after 15 minutes. After right nephrectomy, Piogltazone (10 mg/kg/day, p.o) and Glimepiride (0.5 mg/kg/day, p.o) were administered for 15 days. On the 16th day, ischemia was induced in contra lateral kidney for 45 min, followed by reperfusion for 24 hr. renal function marker and oxidative parameter were estimated at the end of 24 hr reperfusion. At the end of experimental period the level of malondialdehyde formation/ lipid peroxidation (LPO) in kidney tissue and serum marker Creatinine, Urea and Uric acids were significantly increased. Whereas, the activity of biomarkers of oxidative stress such as reduced glutathione (GSH), Catalase (CAT) and superoxide dismutase (SOD) were found to be decreased significantly compared to control rats. Pioglitazone improved the renal dysfunction and oxidative stress after renal ischemia/reperfusion injury in diabetic rats, but Glimepiride less improved the renal marker change compared to treatment of Pioglitazone. In conclusion, Pioglitazone shows potent may improve renal function marker and oxidative stress in kidney in I/R induced renal damage in type 2 diabetic rats.en_US
dc.identifier.citationKakadiya Jagdish, Shah Nehal. Comparison effect of Pioglitazone and Glimepiride alone on renal function marker in experimentally induced renal damage in diabetic rats. Journal of Applied Pharmaceutical Science. 2011 May; 1(3): 72-76.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/150764
dc.language.isoenen_US
dc.source.urihttps://www.japsonline.com/counter.php?aid=38en_US
dc.subjectPioglitazoneen_US
dc.subjectrenal ischemia reperfusion injuryen_US
dc.subjectRenal markeren_US
dc.subjecttype 2 diabetesen_US
dc.titleComparison effect of Pioglitazone and Glimepiride alone on renal function marker in experimentally induced renal damage in diabetic rats.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
japs2011v1n3p72.pdf
Size:
134.52 KB
Format:
Adobe Portable Document Format
Description:
Research article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: